4//SEC Filing
Accardi Mario Alberto 4
Accession 0001847903-25-000113
CIK 0001847903other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 7:42 PM ET
Size
8.9 KB
Accession
0001847903-25-000113
Insider Transaction Report
Form 4
Accardi Mario Alberto
President, Orexin Program
Transactions
- Sale
Ordinary Shares
2025-06-24$14.00/sh−15,000$210,000→ 216,485 total - Exercise/Conversion
Ordinary Shares
2025-06-24$3.85/sh+15,000$57,750→ 231,485 total - Exercise/Conversion
Share Option (right to buy)
2025-06-24−15,000→ 15,300 totalExercise: $3.85Exp: 2033-02-01→ Ordinary Shares (15,000 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025.
- [F3]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0002074392
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 7:42 PM ET
- Size
- 8.9 KB